Company profile: Cytek Biosciences
1.1 - Company Overview
Company description
- Provider of flow cytometry products and services, including Aurora full spectrum profiling flow cytometer (detects up to 40 colors), Aurora CS cell sorter for high-resolution sorting and analysis, Northern Lights cytometer for basic assays to multicolor immunophenotyping, Orion automated reagent cocktail preparation system, Enhanced Small Particle (ESP) detection option for extracellular vesicles, and Amnis AI v3.0 imaging analysis software.
Products and services
- Cytek Aurora™: A full spectrum profiling-based flow cytometer that detects up to 40 colors, delivering detailed cell analysis
- Cytek Northern Lights™: A multicolor immunophenotyping-capable flow cytometer engineered for a range of applications from basic assays to multicolor immunophenotyping
- Cytek Aurora™ CS: A full spectrum profiling-integrated cell sorter that enables high-resolution cell sorting and analysis using spectral profiling
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Cytek Biosciences
Algonomics
HQ: Belgium
Website
- Description: Provider of structural bioinformatics services to develop rationally designed therapeutics in immunotherapy, leveraging a proprietary platform for structure-based protein and peptide design. Belgium-based biotech.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Algonomics company profile →
Biotix
HQ: United States
Website
- Description: Provider of laboratory consumables and liquid handling solutions, including pipette tips (xTIP4, uTIP, aTIP), the Ergonomix manual pipetting system with light ejection, assay and deep well plates made from medical-grade virgin polypropylene, reagent reservoirs certified free of DNase/RNase/endotoxins, OEM custom consumables design and manufacturing, and Defender face shields for splash protection.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Biotix company profile →
Greyson
HQ: United States
Website
- Description: Provider of health and beauty aid products, engaging in their research, development, and marketing.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Greyson company profile →
Natrix Separations
HQ: Canada
Website
- Description: Provider of high-performance single-use and multi-cycle disposable chromatography products for the life science, food, beverage and water markets, featuring technology with high binding capacity, selectivity and specificity normally associated with resin-based chromatography.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Natrix Separations company profile →
BioDot
HQ: United States
Website
- Description: Provider of automated low-volume, non-contact quantitative fluid dispensing systems and lamination, cutting, and assembly expertise. Platforms enable direct dispensing of lines and dots on membranes, papers, microwell plates, slides, and microfluidics, plus web handling and dip coating from roll stock and auto lamination, serving R&D through high-volume manufacturing in industrial, diagnostic, life science, and medical markets.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BioDot company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Cytek Biosciences
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Cytek Biosciences
2.2 - Growth funds investing in similar companies to Cytek Biosciences
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Cytek Biosciences
4.2 - Public trading comparable groups for Cytek Biosciences
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →